Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Thyroid Eye Disease
Related studies linked through entity extraction aliases.
A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid Eye Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Active Thyroid Eye Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Validation of AI-Based Quantitative Eye Movement Analysis From Smartphone 9-Gaze Videos (Glandy EOM)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of IBI3031 in Participants With Thyroid Eye Disease
- Status
- RECRUITING
- Phase
- PHASE1
An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease
- Status
- RECRUITING
- Phase
- PHASE4
A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)
- Status
- COMPLETED
- Phase
- PHASE3
Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)
- Status
- COMPLETED
- Phase
- N/A
A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)
- Status
- COMPLETED
- Phase
- PHASE3